» Articles » PMID: 22362308

Nitric Oxide Release: Part III. Measurement and Reporting

Overview
Journal Chem Soc Rev
Specialty Chemistry
Date 2012 Feb 25
PMID 22362308
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide's expansive physiological and regulatory roles have driven the development of therapies for human disease that would benefit from exogenous NO administration. Already a number of therapies utilizing gaseous NO or NO donors capable of storing and delivering NO have been proposed and designed to exploit NO's influence on the cardiovascular system, cancer biology, the immune response, and wound healing. As described in Nitric oxide release: Part I. Macromolecular scaffolds and Part II. Therapeutic applications, the preparation of new NO-release strategies/formulations and the study of their therapeutic utility are increasing rapidly. However, comparison of such studies remains difficult due to the diversity of scaffolds, NO measurement strategies, and reporting methods employed across disciplines. This tutorial review highlights useful analytical techniques for the detection and measurement of NO. We also stress the importance of reporting NO delivery characteristics to allow appropriate comparison of NO between studies as a function of material and intended application.

Citing Articles

Ratiometric optical dual gas sensor for simultaneous detection of nitric oxide and oxygen intended for healthcare, biological, and biomedical applications.

Rispandi , Chu C, Nugroho S, Ammarullah M RSC Adv. 2024; 14(51):38135-38145.

PMID: 39624427 PMC: 11609819. DOI: 10.1039/d4ra07017h.


The biological effects of copper alloying in Zn-based biodegradable arterial implants.

Morath L, Rahim S, Baker C, Anderson D, Hinds M, Sikora-Jasinska M Biomater Adv. 2024; 167:214112.

PMID: 39561579 PMC: 11634653. DOI: 10.1016/j.bioadv.2024.214112.


Nitric Oxide-Releasing Topical Treatments for Cutaneous Melanoma.

Grayton Q, El-Ahmad H, Lynch A, Nogler M, Wallet S, Schoenfisch M Mol Pharm. 2024; 21(11):5632-5645.

PMID: 39353049 PMC: 11875128. DOI: 10.1021/acs.molpharmaceut.4c00618.


Impact of nitric oxide donors on capsule, biofilm and resistance profiles of Klebsiella pneumoniae.

Nguyen H, Duke M, Grayton Q, Broberg C, Schoenfisch M Int J Antimicrob Agents. 2024; 64(5):107339.

PMID: 39304122 PMC: 11540743. DOI: 10.1016/j.ijantimicag.2024.107339.


Wearable nitric oxide-releasing antibacterial insert for preventing device-associated infections.

Chug M, Sapkota A, Garren M, Brisbois E J Control Release. 2024; 375():667-680.

PMID: 39288891 PMC: 11748947. DOI: 10.1016/j.jconrel.2024.09.027.


References
1.
Liu V, Huang P . Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res. 2007; 77(1):19-29. PMC: 2731989. DOI: 10.1016/j.cardiores.2007.06.024. View

2.
Radermacher P, Santak B, Wust H, Tarnow J, Falke K . Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology. 1990; 72(2):238-44. DOI: 10.1097/00000542-199002000-00005. View

3.
Thomas D, Ridnour L, Espey M, Donzelli S, Ambs S, Hussain S . Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem. 2006; 281(36):25984-93. DOI: 10.1074/jbc.M602242200. View

4.
Borutaite V, Brown G . S-nitrosothiol inhibition of mitochondrial complex I causes a reversible increase in mitochondrial hydrogen peroxide production. Biochim Biophys Acta. 2006; 1757(5-6):562-6. DOI: 10.1016/j.bbabio.2006.02.014. View

5.
Fratacci M, Frostell C, Chen T, Wain Jr J, Robinson D, Zapol W . Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology. 1991; 75(6):990-9. DOI: 10.1097/00000542-199112000-00011. View